National MS Society: Antioxidant Shows Benefit in People With Progressive MS - Early Results From Novel UK Study
September 23, 2026
September 23, 2026
NEW YORK, Sept. 23 -- The National Multiple Sclerosis Society issued the following news:
* * *
September 22, 2026
Antioxidant Shows Benefit in People with Progressive MS - Early Results from Novel UK Study
The MS Society of the United Kingdom has announced interim results from the first stage of the novel "Octopus" trial, reporting that the antioxidant alpha-lipoic acid showed early promise as a treatment for neuroprotection in people . . .
* * *
September 22, 2026
Antioxidant Shows Benefit in People with Progressive MS - Early Results from Novel UK Study
The MS Society of the United Kingdom has announced interim results from the first stage of the novel "Octopus" trial, reporting that the antioxidant alpha-lipoic acid showed early promise as a treatment for neuroprotection in people . . .